FGF2 and metabolic dysfunction-associated steatotic liver disease: Most of the research suggests that IF is effective in reducing hepatic steatosis and fat mass, thereby ameliorating the pathogenesis of NAFLD.[114, 213, 214] Mechanically, IF can activate Fgf2/PPARα signal and elevate the expression of FAO‐related genes.[150, 215] Based on these studies, we speculate that IF may act as a better non‐pharmacological dietary approach to use in clinical practice in alleviating NAFLD.